Do you have a clear understanding of how community pharmacists manage generics and biosimilars?
Generics and biosimilars are playing an increasingly significant role in day-to-day supply within Swiss pharmacies. This market research special report provides exclusive insights into pharmacists’ decision-making and counselling strategies — ranging from product assortment planning and collaboration with manufacturers to patient support at the point of care.
The findings are based on a representative survey of 100 pharmacies across Switzerland. Key topics covered include:
- ✓ Pharmacy profiles: size, location, and affiliation with pharmacy chains or groups
- ✓ Dispensing practices for generics and biosimilars in Swiss pharmacies
- ✓ Patient and customer attitudes and behaviours
- ✓ Manufacturer strategies from the pharmacy perspective
- ✓ Strengths and weaknesses of key manufacturers
- ✓ Impact of product availability and supply reliability
- ✓ Trends and developments in the Swiss generics and biosimilars market
- ✓ Answers to more than 40 relevant industry questions
We look forward to receiving your order and remain at your disposal should you require any additional information.
Order the 2026 Market Research Special Report today:
"Generics and Biosimilars in Swiss Pharmacies"
The Market Research Special Report "Generics and Biosimilars in Swiss Pharmacies" delivers comprehensive, decision-relevant insights into pharmacy-level decision-making and product switching dynamics, while offering a detailed analysis of current market trends and developments in the Swiss generics and biosimilars landscape.
- Price: CHF 5’700